Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of DiaPep277 in newly diagnosed type 1 diabetes
ISRCTN55429664Phase 3Completed
- Sponsor
- Andromeda Biotech Ltd.
- Start
- Oct 2005
- Modality
- Peptides
01
Overview
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing DiaPep277 with Placebo (2 arms). Primary endpoint: Pancreatic beta-cell function. Started Oct 2005; status: completed.
02
Drugs
diapep277
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ISRCTN55429664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN55429664.